JP2006528646A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006528646A5 JP2006528646A5 JP2006521305A JP2006521305A JP2006528646A5 JP 2006528646 A5 JP2006528646 A5 JP 2006528646A5 JP 2006521305 A JP2006521305 A JP 2006521305A JP 2006521305 A JP2006521305 A JP 2006521305A JP 2006528646 A5 JP2006528646 A5 JP 2006528646A5
- Authority
- JP
- Japan
- Prior art keywords
- aryl
- alkyl
- group
- heteroaryl
- heterocycle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003118 aryl group Chemical group 0.000 description 21
- 125000000217 alkyl group Chemical group 0.000 description 18
- 125000001072 heteroaryl group Chemical group 0.000 description 14
- 125000000623 heterocyclic group Chemical group 0.000 description 14
- 229910052739 hydrogen Inorganic materials 0.000 description 10
- 239000001257 hydrogen Substances 0.000 description 10
- -1 aryloxyalkynyl Chemical group 0.000 description 8
- 125000001188 haloalkyl group Chemical group 0.000 description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- 125000003545 alkoxy group Chemical group 0.000 description 7
- 125000001424 substituent group Chemical group 0.000 description 7
- 125000003710 aryl alkyl group Chemical group 0.000 description 6
- 125000000753 cycloalkyl group Chemical group 0.000 description 6
- 125000001475 halogen functional group Chemical group 0.000 description 6
- 125000003342 alkenyl group Chemical group 0.000 description 5
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 4
- 125000004093 cyano group Chemical group *C#N 0.000 description 4
- 125000004446 heteroarylalkyl group Chemical group 0.000 description 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 3
- 125000004181 carboxyalkyl group Chemical group 0.000 description 3
- 125000004438 haloalkoxy group Chemical group 0.000 description 3
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 2
- 125000005129 aryl carbonyl group Chemical group 0.000 description 2
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 2
- 125000005243 carbonyl alkyl group Chemical group 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical group 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 125000004043 oxo group Chemical group O=* 0.000 description 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 125000005080 alkoxycarbonylalkenyl group Chemical group 0.000 description 1
- 125000005086 alkoxycarbonylalkynyl group Chemical group 0.000 description 1
- 125000004686 alkyl sulfanyl alkyl group Chemical group 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000005018 aryl alkenyl group Chemical group 0.000 description 1
- 125000005015 aryl alkynyl group Chemical group 0.000 description 1
- 125000005160 aryl oxy alkyl group Chemical group 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000005019 carboxyalkenyl group Chemical group 0.000 description 1
- 125000004966 cyanoalkyl group Chemical group 0.000 description 1
- 125000005356 cycloalkylalkenyl group Chemical group 0.000 description 1
- 125000005357 cycloalkylalkynyl group Chemical group 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 125000004967 formylalkyl group Chemical group 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 125000004447 heteroarylalkenyl group Chemical group 0.000 description 1
- 125000005312 heteroarylalkynyl group Chemical group 0.000 description 1
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000005343 heterocyclic alkyl group Chemical group 0.000 description 1
- 125000005020 hydroxyalkenyl group Chemical group 0.000 description 1
- 125000005016 hydroxyalkynyl group Chemical group 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000004971 nitroalkyl group Chemical group 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/626,092 | 2003-07-24 | ||
| US10/626,092 US20050020619A1 (en) | 2003-07-24 | 2003-07-24 | Thienopyridine kinase inhibitors |
| US10/838,132 US20050026944A1 (en) | 2003-07-24 | 2004-05-03 | Thienopyridine and furopyridine kinase inhibitors |
| US10/838,132 | 2004-05-03 | ||
| PCT/US2004/024003 WO2005010009A1 (en) | 2003-07-24 | 2004-07-26 | Thienopyridine and furopyridine kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006528646A JP2006528646A (ja) | 2006-12-21 |
| JP2006528646A5 true JP2006528646A5 (enExample) | 2011-03-03 |
| JP4707192B2 JP4707192B2 (ja) | 2011-06-22 |
Family
ID=34108157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006521305A Expired - Fee Related JP4707192B2 (ja) | 2003-07-24 | 2004-07-26 | チエノピリジンおよびフロピリジン系キナーゼ阻害薬 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20050026944A1 (enExample) |
| EP (1) | EP1648905B1 (enExample) |
| JP (1) | JP4707192B2 (enExample) |
| KR (2) | KR101120936B1 (enExample) |
| CN (1) | CN103087078A (enExample) |
| AT (1) | ATE419253T1 (enExample) |
| AU (2) | AU2004259765B2 (enExample) |
| BR (1) | BRPI0412894A (enExample) |
| CA (1) | CA2532982C (enExample) |
| CY (1) | CY1111599T1 (enExample) |
| DE (1) | DE602004018780D1 (enExample) |
| DK (1) | DK1648905T3 (enExample) |
| ES (1) | ES2319302T3 (enExample) |
| IL (1) | IL173348A (enExample) |
| MX (1) | MXPA06000919A (enExample) |
| NZ (1) | NZ544712A (enExample) |
| PL (1) | PL1648905T3 (enExample) |
| PT (1) | PT1648905E (enExample) |
| WO (1) | WO2005010009A1 (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1620094A4 (en) * | 2003-05-06 | 2010-04-28 | Glaxosmithkline Llc | NEW CHEMICAL COMPOUNDS |
| US7899855B2 (en) * | 2003-09-08 | 2011-03-01 | Intel Corporation | Method, apparatus and instructions for parallel data conversions |
| GB0325836D0 (en) * | 2003-11-05 | 2003-12-10 | Celltech R&D Ltd | Biological products |
| TW200538453A (en) * | 2004-04-26 | 2005-12-01 | Bristol Myers Squibb Co | Bicyclic heterocycles as kinase inhibitors |
| US20050256154A1 (en) * | 2004-05-04 | 2005-11-17 | Kin-Chun Luk | 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid amides |
| US20060281768A1 (en) * | 2005-06-10 | 2006-12-14 | Gaul Michael D | Thienopyrimidine and thienopyridine kinase modulators |
| US7566721B2 (en) * | 2005-08-08 | 2009-07-28 | Osi Pharmaceuticals, Inc. | Substituted thienol[2,3-d]pyrimidines as kinase inhibitors |
| MX2008002060A (es) * | 2005-08-16 | 2008-04-16 | Hoffmann La Roche | Nuevas amidas de acido 4-amino-tieno[3,2-c]piridin-7-carboxilico. |
| BRPI0616239A2 (pt) * | 2005-09-15 | 2011-06-14 | Hoffmann La Roche | derivados de Ácido 4-amino-tieno[3,2-c]piridina-7-carboxÍlico, formulaÇço farmacÊutica contendo os mesmos bem como seus usos |
| US20080255184A1 (en) * | 2005-11-04 | 2008-10-16 | Smithkline Beecham Corporation | Thienopyridine B-Raf Kinase Inhibitors |
| EP1968979A2 (en) * | 2005-12-08 | 2008-09-17 | Abbott Laboratories | 9-membered heterobicyclic compounds as inhibitors of protein kinases |
| GB0525164D0 (en) | 2005-12-09 | 2006-01-18 | Xention Discovery Ltd | Compounds |
| CA2635231C (en) * | 2005-12-29 | 2014-07-15 | Abbott Laboratories | Protein kinase inhibitors |
| JP2009528991A (ja) * | 2006-02-14 | 2009-08-13 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼの阻害剤として有用なピロロ（３，２−ｃ）ピリジン |
| US7932390B2 (en) * | 2006-06-29 | 2011-04-26 | Hoffman-La Roche Inc. | Substituted thieno[3,2-C]pyridine carboxylic acid derivatives |
| US7994321B2 (en) * | 2006-08-08 | 2011-08-09 | Hoffmann-La Roche Inc. | Substituted thieno[3,2-C]pyridine-7-carboxylic acid derivatives |
| WO2008018881A1 (en) * | 2006-08-10 | 2008-02-14 | Osi Pharmaceuticals, Inc. | 6,6-bicyclic ring substituted sulfur containing heterobicyclic protein kinase inhibitors |
| MX2010001636A (es) * | 2007-08-14 | 2010-03-15 | Hoffmann La Roche | Derivados de pirazolo[3,4-d]-pirimidina como agentes antiproliferativos. |
| AR070317A1 (es) * | 2008-02-06 | 2010-03-31 | Osi Pharm Inc | Furo (3,2-c) piridina y tieno (3,2-c) piridinas |
| CA2723358A1 (en) * | 2008-05-05 | 2009-11-12 | Allison B. Reiss | Method for improving cardiovascular risk profile of cox inhibitors |
| JP5588458B2 (ja) * | 2008-12-05 | 2014-09-10 | アッヴィ・バハマズ・リミテッド | 癌の治療に使用するためのキナーゼ阻害剤としてのチエノ［３，２−ｃ］ピリジン誘導体 |
| EP2947073B1 (en) * | 2009-10-22 | 2019-04-03 | Fibrotech Therapeutics Pty Ltd | Fused ring analogues of anti-fibrotic agents |
| TWI482770B (zh) * | 2010-06-09 | 2015-05-01 | Abbvie Bahamas Ltd | 結晶型激酶抑制劑 |
| WO2011156473A1 (en) * | 2010-06-09 | 2011-12-15 | Abbott Laboratories | Crystalline forms of kinase inhibitors |
| TWI492949B (zh) * | 2010-06-09 | 2015-07-21 | Abbvie Bahamas Ltd | 結晶型激酶抑制劑 |
| CN102985084A (zh) | 2010-07-02 | 2013-03-20 | 爱尔康研究有限公司 | 用于治疗眼后节病症和疾病的化合物 |
| US8551981B2 (en) * | 2010-10-08 | 2013-10-08 | Abbvie Inc. | Furo[3,2-d]pyrimidine compounds |
| US8436179B2 (en) | 2011-07-20 | 2013-05-07 | Abbvie Inc. | Kinase inhibitor with improved solubility profile |
| CN103396414B (zh) * | 2013-07-16 | 2015-06-03 | 浙江医药高等专科学校 | 咪唑取代的噻唑并环己烷类化合物、及其抗肿瘤用途 |
| CN104945411B (zh) * | 2014-03-27 | 2018-07-31 | 南京勇山生物科技有限公司 | 噻吩并[3,2-c]吡啶类化合物、其制备方法及应用 |
| WO2015157360A1 (en) | 2014-04-08 | 2015-10-15 | Abbvie Inc. | Processes to make protein kinase inhibitors |
| WO2016047678A1 (ja) * | 2014-09-25 | 2016-03-31 | 武田薬品工業株式会社 | 複素環化合物 |
| AU2018215089C1 (en) | 2017-02-03 | 2022-09-22 | Certa Therapeutics Pty. Ltd. | Anti-fibrotic compounds |
| EP4247795A1 (en) | 2020-11-18 | 2023-09-27 | Deciphera Pharmaceuticals, LLC | Gcn2 and perk kinase inhibitors and methods of use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2219178C2 (ru) * | 1997-10-20 | 2003-12-20 | Ф.Хоффманн-Ля Рош Аг | Бициклические производные, фармацевтическая композиция на их основе и промежуточные соединения |
| EP1058549A4 (en) * | 1998-12-23 | 2003-11-12 | Bristol Myers Squibb Pharma Co | FACTOR Xa OR THROMBIN INHIBITORS |
| HUP0303363A2 (hu) * | 1999-09-17 | 2004-07-28 | Abbott Gmbh & Co., Kg | Kináz-inhibitor hatású heterociklusos vegyületek alkalmazása gyógyszerkészítmények előállítására |
| JP3649395B2 (ja) * | 2000-04-27 | 2005-05-18 | 山之内製薬株式会社 | 縮合ヘテロアリール誘導体 |
| US6608053B2 (en) * | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
| ATE297910T1 (de) * | 2001-03-14 | 2005-07-15 | Lilly Co Eli | Retinoid x rezeptormodulatoren |
| WO2003022852A2 (en) * | 2001-09-11 | 2003-03-20 | Smithkline Beecham Corporation | Furo-and thienopyrimidine derivatives as angiogenesis inhibitors |
| EP1620094A4 (en) * | 2003-05-06 | 2010-04-28 | Glaxosmithkline Llc | NEW CHEMICAL COMPOUNDS |
-
2004
- 2004-05-03 US US10/838,132 patent/US20050026944A1/en not_active Abandoned
- 2004-07-26 CN CN2012105340956A patent/CN103087078A/zh active Pending
- 2004-07-26 PT PT04779180T patent/PT1648905E/pt unknown
- 2004-07-26 BR BRPI0412894-0A patent/BRPI0412894A/pt not_active IP Right Cessation
- 2004-07-26 JP JP2006521305A patent/JP4707192B2/ja not_active Expired - Fee Related
- 2004-07-26 AT AT04779180T patent/ATE419253T1/de active
- 2004-07-26 EP EP04779180A patent/EP1648905B1/en not_active Expired - Lifetime
- 2004-07-26 KR KR1020067001692A patent/KR101120936B1/ko not_active Expired - Fee Related
- 2004-07-26 DE DE602004018780T patent/DE602004018780D1/de not_active Expired - Lifetime
- 2004-07-26 NZ NZ544712A patent/NZ544712A/en not_active IP Right Cessation
- 2004-07-26 PL PL04779180T patent/PL1648905T3/pl unknown
- 2004-07-26 DK DK04779180T patent/DK1648905T3/da active
- 2004-07-26 CA CA2532982A patent/CA2532982C/en not_active Expired - Fee Related
- 2004-07-26 ES ES04779180T patent/ES2319302T3/es not_active Expired - Lifetime
- 2004-07-26 AU AU2004259765A patent/AU2004259765B2/en not_active Ceased
- 2004-07-26 WO PCT/US2004/024003 patent/WO2005010009A1/en not_active Ceased
- 2004-07-26 KR KR1020117023338A patent/KR20110123797A/ko not_active Withdrawn
- 2004-07-26 MX MXPA06000919A patent/MXPA06000919A/es active IP Right Grant
-
2006
- 2006-01-24 IL IL173348A patent/IL173348A/en not_active IP Right Cessation
-
2009
- 2009-03-12 CY CY20091100278T patent/CY1111599T1/el unknown
- 2009-12-22 AU AU2009251083A patent/AU2009251083B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006528646A5 (enExample) | ||
| JP2010504286A5 (enExample) | ||
| WO2006055922A3 (en) | Anthranilamide insecticides | |
| JP2009515988A5 (enExample) | ||
| RU2487124C2 (ru) | Новое амидное производное и его использование в качестве лекарственного средства | |
| JP2007529534A5 (enExample) | ||
| WO2009028543A1 (ja) | 置換ピラゾール誘導体 | |
| JP2009536650A5 (enExample) | ||
| WO2005037781A3 (fr) | Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
| JP2009523146A5 (enExample) | ||
| JP2007523139A5 (enExample) | ||
| TW200604186A (en) | Compounds | |
| JP2009532878A5 (enExample) | ||
| RU2018119134A (ru) | Промежуточные продукты для получения пиридазиноновых гербицидов и способ их получения | |
| JP2006508979A5 (enExample) | ||
| RU2010103101A (ru) | Химические соединения | |
| JP2018533580A5 (enExample) | ||
| WO2004099197A3 (de) | Substituierte oxyarene und deren verwendung zur bekämpfung von schädlingen | |
| MX2010001566A (es) | Derivado de aminopirazolamida. | |
| WO2008093668A1 (ja) | キラルなイリジウムアクア錯体およびそれを用いた光学活性ヒドロキシ化合物の製造方法 | |
| JP2004535380A5 (enExample) | ||
| AR045791A1 (es) | Derivados de triazol sustituidos como antagonistas de oxitocina | |
| JP2007517826A5 (enExample) | ||
| RU2007148231A (ru) | Способ синтеза органических соединений | |
| WO2008141469A3 (en) | Butone derivatives useful as cooling agents |